We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
To address the research gaps for chagas disease, we need a consensus on the product profiles in different conditions of use
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The CMA acts to help NHS patients access combination therapies used to treat serious medical conditions.
Projects granted during 2016 that have a primary purpose of translational and applied research - human cancer.
The rules for ensuring patients’ referral to treatment (RTT) waiting time, for consultant-led treatment, is fair and consistent within an 18-week period.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Innovative researchers working to tackle some of the hardest-to-treat cancers, including through the use of AI, have received a £2 million funding boost.
Legislation title: Guidance on the application of Plant Protection Products (PPPs) for phytosanitary treatment of oak processionary moth (OPM).
Government bringing together experts in the field to drive forward progress in tackling cancer in children and young people.
Information and resources on the UK’s plans to see antimicrobial resistance contained and controlled by 2040.
Population screening programmes can cause harms as well as benefits, which need to be weighed up by the UK National Screening Committee (UK NSC).
Guidance for the pharmaceutical industry on how to apply for an authorisation to place a veterinary medicine on the UK market or part of, or to expire one.
Offending behaviour programmes and interventions currently available for offenders in England and Wales.
Guidance for prescribing vets on the use of the cascade.
Definitive fees charged for applications under Schedule 7 of the Veterinary Medicines Regulations 2013.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.